Working Around: The Use of AngioVac and Micra Transcatheter Leadless Pacemaker Implantation in a Critically Ill Patient Receiving Extracorporeal Membrane Oxygenation
DOI:
https://doi.org/10.59958/hsf.6223Keywords:
ECMO, AngioVac, COVID-19, pacemaker, thrombus, ESRDAbstract
The use of extracorporeal membrane oxygenation (ECMO) in critically ill patients has been on the rise in recent years. While ECMO has provided substantial benefit to patients who need cardiopulmonary support, its required use of large-bore catheters in major blood vessels often precludes the use of other transcatheter therapies. In this article, we demonstrate that two transcatheter procedures, AngioVac right-sided cardiac thrombus removal and Micra leadless pacemaker placement, both requiring large bore access, can both be safely and effectively implemented in patients who are dependent on ECMO to maintain cardiopulmonary function.
References
Dalia T, Amr BS. Pacemaker Indications. StatPearls Publishing: USA. 2022.
Lee JZ, Mulpuru SK, Shen WK. Leadless pacemaker: Performance and complications. Trends in Cardiovascular Medicine. 2018; 28: 130–141.
Cunn G, Goldner B, Epstein LM. Will it fit? Leadless pacemaker implantation in a patient on extracorporeal membrane oxygenation. HeartRhythm Case Reports. 2022; 8: 805–806.
Supady A, Combes A, Barbaro RP, Camporota L, Diaz R, Fan E, et al. Respiratory indications for ECMO: focus on COVID-19. Intensive Care Medicine. 2022; 48: 1326–1337.
Murphy DA, Hockings LE, Andrews RK, Aubron C, Gardiner EE, Pellegrino VA, et al. Extracorporeal membrane oxygenation-hemostatic complications. Transfusion Medicine Reviews. 2015; 29: 90–101.
Wool GD, Miller JL. The Impact of COVID-19 Disease on Platelets and Coagulation. Pathobiology: Journal of Immunopathology, Molecular and Cellular Biology. 2021; 88: 15–27.
Sangalli F, Greco G, Galbiati L, Formica F, Calcinati S, Avalli L. Regional thrombolysis with tenecteplase during extracorporeal membrane oxygenation: a new approach for left ventricular thrombosis. Journal of Cardiac Surgery. 2015; 30: 541–543.
Combes A, Hajage D, Capellier G, Demoule A, Lavoué S, Guervilly C, et al. Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome. The New England Journal of Medicine. 2018; 378: 1965–1975.
Tarzia V, Ponzoni M, Tessari C, Evangelista G, Zanella F, Pittarello D, et al. Navigating the Heart. The Evolution of the AngioVac System in a Single-center Experience. Current Problems in Cardiology. 2023; 48: 101543.
Renew JR, Wittwer ED, Robb TM, Fritock MD. AngioVac Removal of a Saddle Pulmonary Embolus Using TEE Guidance and Venoarterial ECMO Support. Journal of Cardiothoracic and Vascular Anesthesia. 2016; 30: 749–752.
Shanmugasundaram M, Chatterjee A, Lee K. Percutaneous Large Thrombus and Vegetation Evacuation in the Catheterization Laboratory. Interventional Cardiology Clinics. 2022; 11: 349–358.
Griffith KE, Jenkins E, Copenhaver W, Williams DM. Novel use of the AngioVac® system to remove thrombus during simultaneous extracorporeal membrane oxygenation life support. Perfusion. 2016; 31: 164–168.
Priest JR, Brown M, Choi D, Thiagarajan R, Roy N, Esch J, et al. Modified AngioVac System use With Extracorporeal Membrane Oxygenation in a Child With Fontan Thrombosis. ASAIO Journal. 2022; 68: e48–e52.
